The effect of the ergoline derivative, CU 32-085, on prolactin secretion in hyperprolactinemic women**Supported in part by a grant-in-aid from Sandoz, Inc., National Institute of Health grant ST33AM07039 (Dr. Rodman), and United States Public Health Service grant RR 054 to the Clinical Research Center of Tufts-New England Medical Center.-Reference-Cited by-同舟云学术

The effect of the ergoline derivative, CU 32-085, on prolactin secretion in hyperprolactinemic women**Supported in part by a grant-in-aid from Sandoz, Inc., National Institute of Health grant ST33AM07039 (Dr. Rodman), and United States Public Health Service grant RR 054 to the Clinical Research Center of Tufts-New England Medical Center.

Published:1987-10 Issue:4 Volume:48 Page:555-559
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Hesla John S.,Rodman Elise F.,Molitch Mark E.,Goodman Lisa A.,Jeffrey Chang R.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference16 articles.

1. Two novel prolactin release-inhibiting 8α-aminoergolines;Flückiger;Experientia,1979

2. Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H] dihydroergocryp-tine binding with the dopaminergic control of prolactin release;Caron;J Biol Chem,1978

3. Puerperal lactation inhibition with a novel 8α-amino-ergo-line (CU 32-085);Poulsen;Gynecol Obstet Invest,1984

4. The effect of a new ergoline derivative, CU 32-085, in the treatment of acromegaly: a controlled study;Eskildsen;Clin Endocrinol (Oxf),1985

5. Treatment of Parkinson’s disease with the ergoline derivatives CQ 32-084 and CU 32-085;Pakkenberg;Adv Neurol,1983

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesulergine: A Review;CNS Drug Reviews;2006-06-07

2. Bromocriptine and Related Compounds for Ovulation Induction in Hyperprolactinemia;Clinical Perspectives in Obstetrics and Gynecology;1991